Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: Mammostrat®as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy

Figure 2

Exploratory analysis. Kaplan-Meier distant recurrence-free survival (DRFS) survival cures for breast-conserving surgery cases. Solid lines, Mammostrat® score low risk; dotted lines, Mammostrat® score medium risk; grey lines, Mammostrat® score high risk. (a) All estrogen receptor (ER)-positive breast cancers. (b) All breast cancers regardless of treatment and hormonal status. (c) Untreated breast cancers. (d) ER-negative breast cancers.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us